Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Treatment of refractory subacute cutaneous lupus erythematosus with oral isotretinoin: a valid therapeutic option.

D'Erme AM, Milanesi N, Difonzo EM, Lotti T, Gola M.

Dermatol Ther. 2012 May-Jun;25(3):281-2. doi: 10.1111/j.1529-8019.2012.01461.x. No abstract available.

PMID:
22913448
2.

[Use of oral isotretinoin in the treatment of cutaneous lupus erythematosus].

Vena GA, Coviello C, Angelini G.

G Ital Dermatol Venereol. 1989 Jun;124(6):311-5. Italian.

PMID:
2630441
4.

Subacute cutaneous lupus erythematosus response to isotretinoin.

Furner BB.

Int J Dermatol. 1990 Oct;29(8):587-90. No abstract available.

PMID:
2242950
5.

Methotrexate treatment for refractory subacute cutaneous lupus erythematosus.

Kuhn A, Specker C, Ruzicka T, Lehmann P.

J Am Acad Dermatol. 2002 Apr;46(4):600-3.

PMID:
11907517
6.

Isotretinoin for refractory lupus erythematosus.

Shornick JK, Formica N, Parke AL.

J Am Acad Dermatol. 1991 Jan;24(1):49-52.

PMID:
1999529
7.

Cyclosporin combined with methotrexate in two patients with recalcitrant subacute cutaneous lupus erythematosus.

Klein A, Vogt T, Wenzel SM, Fleck M, Landthaler M.

Australas J Dermatol. 2011 Feb;52(1):43-7. doi: 10.1111/j.1440-0960.2010.00689.x. Epub 2010 Aug 24.

PMID:
21332692
8.

A case of herpes zoster during pimecrolimus use for the treatment of subacute cutaneous lupus erythematosus.

Tatlican S, Eren C, Atacan D, Dalgic U, Canpolat F, Eskioglu F.

J Dermatolog Treat. 2010 Sep;21(5):322-3. doi: 10.3109/09546630903287460. No abstract available.

PMID:
19832287
9.

Rapid improvement of subacute cutaneous lupus erythematosus with low-dose methotrexate.

Böhm L, Uerlich M, Bauer R.

Dermatology. 1997;194(3):307-8. No abstract available.

PMID:
9187859
10.

[Classification of dermatologic manifestations in lupus erythematosus].

Francès C, Barete S, Ayoub N, Piette JC.

Ann Med Interne (Paris). 2003 Feb;154(1):33-44. French.

PMID:
12746657
11.

Treatment with oral cyclosporin A of a case of vesicular cutaneous lupus erythematosus in a rough collie.

Font A, Bardagi M, Mascort J, Fondevila D.

Vet Dermatol. 2006 Dec;17(6):440-2.

PMID:
17083576
12.

Thalidomide in cutaneous lupus erythematosus.

Pelle MT, Werth VP.

Am J Clin Dermatol. 2003;4(6):379-87. Review.

PMID:
12762830
13.

Pulse cyclophosphamide treatment for severe refractory cutaneous lupus erythematosus.

Raptopoulou A, Linardakis C, Sidiropoulos P, Kritikos HD, Boumpas DT.

Lupus. 2010 May;19(6):744-7. doi: 10.1177/0961203309358601. Epub 2010 Feb 23.

PMID:
20179172
14.

Solitary hypertrophic lupus erythematosus of the nose without other cutaneous or systemic involvement.

Bettoli V, Minghetti S, Ferron P, Borghi A, Virgili A.

Int J Dermatol. 2014 Jan;53(1):e18-20. doi: 10.1111/j.1365-4632.2011.05349.x. Epub 2012 Dec 11. No abstract available.

PMID:
23231036
15.

Thalidomide in the treatment of refractory cutaneous lupus erythematosus: prognostic factors of clinical outcome.

Cortés-Hernández J, Torres-Salido M, Castro-Marrero J, Vilardell-Tarres M, Ordi-Ros J.

Br J Dermatol. 2012 Mar;166(3):616-23. doi: 10.1111/j.1365-2133.2011.10693.x. Epub 2012 Jan 19.

PMID:
21999437
16.

Low-dose thalidomide therapy for refractory cutaneous lesions of lupus erythematosus.

Housman TS, Jorizzo JL, McCarty MA, Grummer SE, Fleischer AB Jr, Sutej PG.

Arch Dermatol. 2003 Jan;139(1):50-4.

PMID:
12533164
17.

Linear cutaneous lupus erythematosus in the lines of Blaschko.

Engelman DE, Kotz EA 3rd, Maize JC Sr.

Pediatr Dermatol. 2007 Mar-Apr;24(2):125-9.

PMID:
17461806
18.

Treatment of cutaneous lupus with Elidel.

Zabawski E.

Dermatol Online J. 2002 Oct;8(2):25. No abstract available.

PMID:
12546779
19.

Patients with cutaneous lupus erythematosus who smoke are less responsive to antimalarial treatment.

Jewell ML, McCauliffe DP.

J Am Acad Dermatol. 2000 Jun;42(6):983-7.

PMID:
10827400
20.

American experience with low-dose thalidomide therapy for severe cutaneous lupus erythematosus.

Duong DJ, Spigel GT, Moxley RT 3rd, Gaspari AA.

Arch Dermatol. 1999 Sep;135(9):1079-87.

PMID:
10490113

Supplemental Content

Support Center